Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study

American Journal of Clinical Nutrition

Volumn 68, Issue 3, 1998, Pages 568-575

  Djoussé, Luc ^a   Ellison, R Curtis ^b   Zhang, Yuqing ^b   Arnett, Donna K ^b   Sholinsky, Phyliss ^b   Borecki, Ingrid ^b  

^a BOSTON UNIVERSITY   (United States)

^b NONE

Author keywords

Cardiovascular disease; Dietary fiber; Fibrinogen; PAI 1; Plasminogen activator inhibitor type 1; Waist hip ratio

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR;

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CORRELATION FUNCTION; DIETARY FIBER; FAMILY STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0031688889     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.3.568     Document Type: Article

References (63)

1. Khaw K, Barrett-Connor E. Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol 1987;126:1093-102.
2. Humble CG, Malarcher AM, Tyroler HA. Dietary fiber and coronary heart disease in middle-aged hypercholesterolemic men. Am J Prev Med 1993;9:197-202.
3. Pietinen P, Rimm EB, Korhonen P, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 1996;94:2720-7.
4. Kromhout D, Coulander CL. Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. Am J Epidemiol 1984;119:733-41.
5. Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fiber and 10-year mortality from coronary heart disease, cancer and all causes: the Zutphen Study. Lancet 1982;2:518-22.
6. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J 1977;2:1307-14.
7. Kushi LH, Lew RA, Stare FJ, et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl J Med 1985;312:811-8.
8. Fehily AM, Yarnell JWG, Sweetnam PM, Elwood PC. Diet and incident ischaemic heart disease: the Caerphilly Study. Br J Nutr 1993;69:303-14.
9. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-51.
10. Kirby RW, Anderson JW, Sieling B, et al. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981;34:824-9.
11. Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 1984;40:1146-55.
12. Anderson JW, Gilinsky NH, Deakins DA, et al. Lipid responses of hypercholesterolemic men to oat-bran and wheat-bran intake. Am J Clin Nutr 1991;54:678-83.
13. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988; 148:292-6.
14. Anderson JW, Smith BM, Gustafson NJ. Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr 1994; 59(suppl):1242S-7S.
15. Trowell HC. Dietary-fiber hypothesis of the etiology of diabetes mellitus. Diabetes 1975;24:762-5.
16. Anderson JW, Gustafson NJ, Bryant CA, Tietyen-Clark J. Dietary fiber and diabetes: a comprehensive review and practical application. J Am Diet Assoc 1987;87:1189-97.
17. Boman K, Hellsten G, Bruce A, Hallmans G, Nilsson TK. Endurance physical activity, diet and fibrinolysis. Atherosclerosis 1994;106:65-74.
18. Fehily AM, Milbank JE, Yarnell JW, Hayes TM, Kubiki AJ, Eastham RD. Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure. Am J Clin Nutr 1982;36:890-6.
19. Yarnell JWG, Fehily AM, Milbank J, Kubiki AJ, Eastham R, Hayes TM. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J Epidemiol Community Health 1983;37:137-40.
20. Fehily AM, Burr ML, Butland BK, Eastham RD. A randomized controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen. J Epidemiol Community Health 1986;40:334-7.
21. Higgins M, Province M, Heiss G, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996;143:1219-28.
22. Von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimung des Fibrinogens. (Physiologic fast method for measurement of fibrinogen.) Acta Haematol 1957;17:237-46 (in German).
23. de Clerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D.Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988;71:220-5.
24. Stein AD, Shea S, Basch CE, Contento IR, Zybert P. Consistency of the Willett semiquantitative food frequency questionnaire and 24-hour dietary recalls in estimating nutrient intakes of preschool children. Am J Epidemiol 1992;135:667-77.
25. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
26. Southgate DAT. Determination of food carbohydrate. London: Applied Science, 1976.
27. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor land atherothrombosis. Thromb Haemost 1993;70:138-43.
28. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Hematological stress syndrome in atherosclerosis. J Clin Pathol 1981; 34:464-7.
29. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997;277:472-7.
30. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
31. Meilahn EN, Cauley JA, Tracy RP, Macy EO, Gutai JP, Kuller LH. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women. Am J Epidemiol 1996;143:159-66.
32. Stefanick ML, Legault C, Tracy RP, et al. Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Arterioscler Thromb Vase Biol 1995;15:2085-93.
33. Gebara OCE, Mittleman MA, Sutherland P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952-8.
34. Landin K, Stigendal L, Eriksson E, et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990;39:1044-8.
35. Vague P, Juhan-Vague I, Aillaud MF, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin, and relative body weight in normal and obese subjects. Metabolism 1986;35:250-3.
36. Meade TW, Brozovic M, Chakrabarti RR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7.
37. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076-9.
38. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-6.
39. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM Study in healthy men. Arterioscler Thromb 1994;14:54-9.
40. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118:956-63.
41. Hamsten A, Walldius G, Szamosi A, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
42. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
43. Nilsson TK, Sundell IB, Hellsten G, Hallman G. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables. J Intern Med 1990;227:267-71.
44. Sundell IB, Ranby M. Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 1993;23:45-50.
45. Marckmann P, Sandstrom B, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993;101:225-34.
46. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
47. Marlett JA, Cheung T. Dietary fiber guidelines in the exchange lists for menu planning. Diabetes Care 1994;17:1534-41.
48. Simpson HCR, Mann JI, Chakrabarti R, et al. Effects of high-fibre diet on haemostatic variables in diabetes. Br Med J 1982;284:1608.
49. Miller GJ, Martin JC, Webster J, et al. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Atherosclerosis 1986;60:269-77.
50. Vorster HH, Cummings JH, Veldman FJ. Diet and haemostasis: time for nutrition science to get more involved. Br J Nutr 1997; 77:671-84.
51. Venter CS, Vorster HH, Van der Nest D. Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed "Western" diets. J Nutr 1990;120:1046-53.
52. Chen WL, Anderson JW, Jennings D. Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med 1984;175:215-8.
53. Cummings JH, Englyst HN. Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 1987;45:1243-55.
54. Venter CS, Vorster HH. Possible metabolic consequences of fermentation in the colon for humans. Med Hypotheses 1989;29:161-6.
55. Pilgeram LO, Pickart LR. Control of fibrinogen biosynthesis: the role of free fatty acid. J Artheroscler Res 1968;8:155-66.
56. Isaksson G, Asp NG, Ihse I. Effects of dietary fiber on pancreatic enzyme activities of ileostomy evacuates and on excretion of fat and nitrogen in the rat. Scand J Gastroenterol 1983;18:417-23.
57. Juhan-Vague I, Thompson SG, Jespersen J. Involvement of hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb 1993; 13:1865-73.
58. Hubert, HB, Feinleib M, McNamara, PM, Castelli WP. Obesity as independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
59. Shaper AG, Pocock SJ. Risk factors for ischemic heart disease in British men. Br Heart J 1987;57:11-6.
60. Coleman MP, Key TJA, Wang DY, et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Atherosclerosis 1992;92:177-85.
61. Folsom AR, Qamhieh HT, Wing RR, et al. Impact of weight loss on plasminogen activator (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 1993;13:162-9.
62. Eliasson M, Evrin PE, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden Monica Study. J Clin Epidemiol 1994;47:513-24.
63. Avellone G, Di Garbo V, Cordova R, Raneli G, De Simone R, Bonipiani GD, Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994;75:223-31.